Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Stenosis

Stenosis

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Stenosis

11 trials tracked for Stenosis: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 404 citations.

11Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Other / NA 10
  1. Phase 4 Tailored Antiplatelet Therapy Following PCI Completed · 404 cited
  2. N/A BIONICS Israel Trial Completed
  3. N/A Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft Completed
  4. N/A Anterior Bridging Cage With Bone Substitute Versus Localized Autobone in Transforaminal Lumbar Interbody Arthrodesis Completed
  5. N/A Efficacy and Safety of Accell Evo3 Demineralized Bone Matrix (DBM) in Instrumented Posterolateral Lumbar Spine Fusion Completed
  6. N/A OsteoStrux™ Collagen Ceramic Scaffold in Instrumented Lumbar Spine Fusion Completed
Show 5 more trials
  1. N/A Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion Completed
  2. N/A Efficacy and Safety of Integra Accell Evo3 DBM in Instrumented Lumbar Spine Fusion Completed
  3. N/A Image Quality and Radiation Dose in Angiography Completed
  4. N/A PMS Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention Completed
  5. N/A Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA) Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Stenosis: what the trials found

For patients undergoing posterolateral fusion, clinical outcomes demonstrate significant improvements in functional status and disability scores over a 24-month period. Specifically, the Oswestry Disability Index (ODI) improved from 50.0 to 33.7 during this timeframe 6. Patient-reported quality of life, as measured by the EQ-5D Health State Visual Analog Scale (VAS), showed an increase from 58.8 at baseline to 79.2 within 6 months, remaining stable through 24 months 6.

Radiographic evidence confirms successful fusion in posterolateral fusion procedures; CT scans demonstrated a 26% fusion rate across spinal levels 4. Additionally, X-ray assessments of posterolateral gutters showed consistent evidence of arthrodesis at 3, 6, 12, and 24 months post-procedure 6.

Clopidogrel was evaluated in a large-scale Phase 4 study involving 5,276 participants 1.

Recent results — preliminary, needs further review

  • Transforaminal lumbar interbody arthrodesis (n=69) 2
  • BioNIR Ridaforolimus Eluting Coronary Stent System (n=58) 3
  • Saphenous vein graft (SVG) stenting showed 5 participants with adverse events within 30 days (n=12) 5
  • Covera Vascular Covered Stent following PTA demonstrated high target lesion primary patency (TLPP) and freedom from serious adverse events in two separate trials [7, 8]
  • Demineralized Bone Matrix showed radiographic fusion at 12 months post-surgery (n=43) 9

For the clinician treating this condition

  • Posterolateral fusion is associated with measurable improvements in patient disability scores (ODI) and quality of life (EQ-5D VAS) over a 24-month period 6.
  • Radiographic evidence supports the efficacy of posterolateral fusion for achieving arthrodesis at multiple follow-up intervals [4, 6].

AI synthesis of 7 cited trials, updated Jul 12, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.